Author: Hiatt, Andrew; Zeitlin, Larry; Whaley, Kevin J.
Title: Multiantibody Strategies for HIV Cord-id: mglg0vb5 Document date: 2013_6_6
ID: mglg0vb5
Snippet: Vaccination strategies depend entirely on the appropriate responsiveness of our immune system against particular antigens. For this active immunization to be truly effective, neutralizing antibodies (nAbs) need to efficiently counter the infectivity or propagation of the pathogen. Some viruses, including HIV, are able to take advantage of this immune response in order to evade nAbs. This review focuses on viral immune evasion strategies that result directly from a robust immune response to infec
Document: Vaccination strategies depend entirely on the appropriate responsiveness of our immune system against particular antigens. For this active immunization to be truly effective, neutralizing antibodies (nAbs) need to efficiently counter the infectivity or propagation of the pathogen. Some viruses, including HIV, are able to take advantage of this immune response in order to evade nAbs. This review focuses on viral immune evasion strategies that result directly from a robust immune response to infection or vaccination. A rationale for multi-Ab therapy to circumvent this phenomenon is discussed. Progress in the formulation, production, and regulatory approval of monoclonal antibodies (mAbs) is presented.
Search related documents:
Co phrase search for related documents- active infection and address need: 1
- acute sars cov respiratory syndrome coronavirus and additional mabs: 1
- acute sars cov respiratory syndrome coronavirus and additional strategy: 1
- acute sars cov respiratory syndrome coronavirus and additive reactivity: 1
- acute sars cov respiratory syndrome coronavirus and address need: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- additional strategy and address need: 1, 2
Co phrase search for related documents, hyperlinks ordered by date